OPEN Journal of the American Board of Family Medicine : JABFM | 14 Jan 2018
LP Hurley, MA Allison, T Pilishvili, ST O'Leary, LA Crane, M Brtnikova, BL Beaty, MC Lindley, CB Bridges and A Kempe
In 2012, the Advisory Committee on Immunization Practices recommended 13-valent pneumococcal conjugate vaccine (PCV13) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23) for at-risk adults ≥19; in 2014, it expanded this recommendation to adults ≥65. Primary care physicians' practice, knowledge, attitudes, and beliefs regarding these recommendations are unknown.
* Data courtesy of Altmetric.com